Clinical trial
Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)
NCT00238537 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00238537 |
|---|---|
| Title | Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) |
| Official title | Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) in Acute Stroke |
| Lead sponsor | Melbourne Health, Other |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | Alteplase t-PA |
| Enrollment | 100 |
| Start date | Aug 1, 2001 |
| Completion | Apr 1, 2007 |
| First posted | Oct 13, 2005 |
| Last update posted | May 30, 2013 |
| Countries | Australia, Belgium, New Zealand, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: